ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,353Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 389

$427K Total Retail Price of All Prescriptions

Rank: 83 out of 389

273 Patients Receiving at Least One Drug in Part D
80% Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

11% of this provider’s 273 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 327 305 35 1 6
LISINOPRIL 275 231 49 2 2
LEVOTHYROXINE SODIUM 262 188 43 3 3
ATORVASTATIN CALCIUM 241 185 35 4 1
AMLODIPINE BESYLATE 197 157 32 5 5
METFORMIN HCL 177 134 28 6 8
HYDROCHLOROTHIAZIDE 174 161 29 7 7
SIMVASTATIN 163 131 28 8 4
METOPROLOL TARTRATE 154 136 30 9 10
ESCITALOPRAM OXALATE 150 119 25 10 22
OMEPRAZOLE 147 101 25 11 9
HYDROCODONE-ACETAMINOPHEN 116 95 22 S3 12 16
TRAZODONE HCL 114 89 15 13 24
CITALOPRAM HBR 111 81 14 14 32
WARFARIN SODIUM 110 92 19 15 12
METOPROLOL SUCCINATE 107 102* 17 16 11
LOSARTAN POTASSIUM 100 100 15 17 15
ZOLPIDEM TARTRATE 95 68 16 18 19
MIRTAZAPINE 91 80 14 19 45
GABAPENTIN 87 62 12 20 17
ATENOLOL 82 70 18 21 14
LOVASTATIN 78 65 12 22 50
CELEBREX 77 72* 11 23 83
SERTRALINE HCL 72 <11 <11 24 20
NEXIUM 70 40 12 25 23
DONEPEZIL HCL 67 <11 <11 26 31
CLOPIDOGREL 64 39 11 27 29
LORAZEPAM 60 42 14 B 28 27
NAMENDA 60 <11 <11 28 36
PANTOPRAZOLE SODIUM 60 55* 13 28 25
DIOVAN 58 <11 <11 31 28
ALPRAZOLAM 56 44 18 B 32 18
OXYCODONE HCL-ACETAMINOPHEN 56 <11 <11 S2 32 91
FLUTICASONE PROPIONATE 54 37 18 34 49
MONTELUKAST SODIUM 54 <11 <11 34 42
CRESTOR 52 47* 11 36 21
POTASSIUM CHLORIDE 51 <11 <11 37 34
FLUOXETINE HCL 50 <11 <11 38 62
ADVAIR DISKUS 50 <11 <11 38 41
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.